USS Investment Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

USS Investment Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.53M	Buy	+10,500	New	+$2.3M	0.01%	487
2023 Q3	–	Sell	-19,174	Closed	-$2.38M	–	584
2023 Q2	$2.38M	Hold	19,174	–	–	0.03%	485
2023 Q1	$2.8M	Buy	19,174 +798	+4%	+$118K	0.04%	453
2022 Q4	$2.93M	Hold	18,376	–	–	0.04%	439
2022 Q3	$2.45M	Sell	18,376 -4,547	-20%	-$691K	0.04%	455
2022 Q2	$3.58M	Sell	22,923 -870	-4%	-$134K	0.04%	453
2022 Q1	$3.71M	Buy	23,793 +10,390	+78%	+$1.51M	0.03%	504
2021 Q4	$1.71M	Hold	13,403	–	–	0.01%	655
2021 Q3	$1.75M	Buy	13,403 +9,864	+279%	+$1.49M	0.01%	649
2021 Q2	$629K	Hold	3,539	–	–	0.01%	573
2021 Q1	$582K	Hold	3,539	–	–	0.01%	564
2020 Q4	$584K	Sell	3,539 -23,200	-87%	-$3.46M	0.01%	549
2020 Q3	$3.82M	Hold	26,739	–	–	0.04%	256
2020 Q2	$2.95M	Buy	26,739 +13,639	+104%	+$1.51M	0.03%	284
2020 Q1	$1.31M	Hold	13,100	–	–	0.02%	219
2019 Q4	$1.96M	Buy	+13,100	New	+$1.78M	0.02%	163

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

USS Investment Management's JAZZ Position: Q2 2026 in Review

USS Investment Management opened a new position in Jazz Pharmaceuticals (JAZZ) in Q2 2026: 10,500 shares worth $2.53M. The stake represents 0.01% of the portfolio and ranks #487 among its holdings. This is a return to the name: USS Investment Management previously reported a position in JAZZ as recently as Q2 2023.

USS Investment Management first reported a position in JAZZ in Q4 2019 and has held it in 16 quarters since. The position peaked at $3.82M in Q3 2020. 647 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

USS Investment Management held 10,500 shares of Jazz Pharmaceuticals worth $2.53M as of Q2 2026.
Jazz Pharmaceuticals was a new USS Investment Management position in Q2 2026.
Jazz Pharmaceuticals made up 0.01% of USS Investment Management's portfolio in Q2 2026, its #487 holding.
USS Investment Management first reported a position in Jazz Pharmaceuticals in Q4 2019 and has held it in 16 quarters since.
USS Investment Management's Jazz Pharmaceuticals position peaked at $3.82M in Q3 2020.
647 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on USS Investment Management's 13F filing for Q2 2026, filed 11 Aug 2026.